secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001493152-22-031105
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions acquires IFP, reports Q1 net loss of $1.21M, cash $5.74M
--------------------------------------------------------------------------------

- Acquired Intelligent Fingerprinting Limited (IFP) for its sweat-based fingerprint drug screening technology.
- Net loss $1.21M ($0.08 per share) vs $1.43M ($0.10) prior year; cash $5.74M as of Sept 30, 2022.
- New customer wins: Goldstar Transport, Eastern Airways, and Glass Systems Group adopted IFP drug test.
- Board additions: David Jenkins (CEO of Catheter Precision) and Jason Isenberg appointed in October.
- Cash runway expected into first half of calendar 2023; excludes potential new market revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315222031105/0001493152-22-031105-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315222031105/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-031105

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer